POZEN Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Chapel Hill NC United States (1996)
Status: Acquired by Aralez Pharmaceuticals (2015)

Organization Overview

First Clinical Trial
2004
NCT00442221
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

C. Phillip O'Carroll | C. Phillip O'Carroll, MD, Inc.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 3)

Headache (Phase 3)

Migraine Disorders (Phase 3)

Osteoarthritis (Phase 3)

Spondylitis (Phase 3)

Spondylitis, Ankylosing (Phase 3)

Stomach Ulcer (Phase 3)

Ulcer (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 30
  • # of Trial APIs: 11